Envestnet Asset Management »

Akero Therapeutics shares owned by Envestnet Asset Management

Quarter-by-quarter ownership of Akero Therapeutics (AKRO) shares owned by Envestnet Asset Management from 13F filings

Historical chart of Envestnet Asset Management investment in Akero Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Akero Therapeutics held by Envestnet Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Akero Therapeutics by Envestnet Asset Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $307k 11k 28.69
2024-03-31 $364k 14k 25.26
2023-09-30 $477k 9.4k 50.58

More positions owned by Envestnet Asset Management

Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr Core Total Usd (IUSB)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Ishares Tr Msci Usa Qlt Fct (QUAL)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Ishares Tr Core Us Aggbd Et (AGG)
Ishares Tr S&p 500 Grwt Etf (IVW)
Microsoft Corporation (MSFT)
Vanguard Bd Index Fds Short Trm Bond (BSV)
Vanguard Index Fds Value Etf (VTV)
Blackrock Etf Trust Us Eqt Factor (DYNF)
Vanguard Index Fds Growth Etf (VUG)
Ishares Tr Eafe Value Etf (EFV)
Ishares Tr Core Msci Eafe (IEFA)
Apple (AAPL)

View all positions for Envestnet Asset Management

Top funds holding Akero Therapeutics

Henderson Group
BlackRock
BlackRock
General Atlantic
T. Rowe Price Associates
Vanguard Group
State Street Corporation
Alliancebernstein
Perceptive Advisors
Boxer Capital
Geode Capital Management
Redmile Group
Point72 Asset Management
T. Rowe Price Investment Management
Baker Bros. Advisors

View all funds holding Akero Therapeutics